Systems Medicine


Systems Medicine Overview


We investigate pathomechanisms of diseases to improve diagnostics and treatment protocols based on mathematical modeling. Especially, we are working on quantitative descriptions of cellular pathways involved in cancer to support the development of improved therapeutic strategies in oncology. Inspired by the motto “semper apertus” of our university, we are always open for exchange and collaborations with other research groups across disciplines to move towards a functional understanding in pathophysiology and translational medical research.


Mathematical modeling in medicine and cellular biology

The systems medicine team is dedicated to applications of mathematical modeling in medicine and cellular biology. Our aim is to understand functional aspects of signal transduction systems in cells with focus on cancer research. To this end, we combine different types of mathematical models with biological experiments or clinical data. To calibrate models, we apply experimental methods for protein quantification, microscopy as well as sequencing techniques. In particular, we perform live-cell imaging to quantify processes in single cells and capture heterogeneity in cell populations. Recently, we developed a microscopy platform for automated live-cell imaging and perfusion with chemotherapeutic drugs called CytoScanner. Using this platform and algorithms from the field of machine learning, we want to optimize administration schedules of chemotherapeutic drugs.

Based on mathematical modeling, biomedical problems such as the initiation of apoptosis by pro-caspase-8 cis-/trans-cleavage, CRISPR/Cas9-mediated gene editing, or the early detection of atrial fibrillation were addressed.

Health Data Science

Furthermore, we are active on the field of data science in medicine. In this context, we work on developing predictive models for diagnostic applications and the early detection of diseases. Previosly, we established and clinically validated the ECHO-AF scores to predict the presence of paroxysmal atrial fibrillation (pAF) using non-invasive medical history and echocardiographic parameters (

Stefan Kallenberger

Dr. med. Dr. rer. nat. Stefan M. Kallenberger was educated as physician and physicist and works in the areas of systems medicine and systems biology. He is a member of the Hub for Innovations in Digital Health at Heidelberg University and the National Center for Tumor Diseases. His scientific work covers applications of mathematical models for understanding biochemical pathways, characterizing pathomechanisms, and for improving the early detection of diseases.

Dr. Dr. Stefan Kallenbeger

Group leader at BioQuant-Zentrum

BioQuant-Zentrum BQ054
Im Neuenheimer Feld 267
69120 Heidelberg

Research Group


Dr. Nelida López Palau
Postdoctoral researcher
BioQuant-Zentrum BQ054
Im Neuenheimer Feld 267
69120 Heidelberg
Pablo Naranjo
Doctoral student
BioQuant-Zentrum BQ054
Im Neuenheimer Feld 267
69120 Heidelberg
Caroline Hess
Master student
BioQuant-Zentrum BQ054
Im Neuenheimer Feld 267
69120 Heidelberg
Judith Hesse
M.D. student
BioQuant-Zentrum BQ054
Im Neuenheimer Feld 267
69120 Heidelberg

Selected publications

Adam L*, Stanifer M*, Springer F, Mathony J, Brune M, Di Ponzio C, Eils R, Boulant S, Niopek D#, Kallenberger SM#. Transcriptomics-inferred dynamics of SARS-CoV-2 interactions with host epithelial cells. Sci Signal. 2023;16: eabl8266. (*shared first authors, #corresponding authors)


Klein P*, Kallenberger SM*, Roth H, Roth K, Ly-Hartig TBN, Magg V, Aleš J, Talemi, SR, Qiang Y, Wolf S, Oleksiuk O, Kurilov R, Di Ventura B, Bartenschlager R, Eils R, Rohr K, Hamprecht FA, Höfer T, Fackler OT, Stoecklin G, Ruggieri A. Temporal control of the integrated stress response by a stochastic molecular switch. Science Advances 2022, 8, eabk202, (*shared first authors)


Schmidt C, Benda S, Kraft P, Wiedmann F, Pleger S, Büscher A, Thomas D, Wachter R, Schmid C, Eils R, Katus HA, Kallenberger SM. Prospective multicentric validation of a novel prediction model for paroxysmal atrial fibrillation. Clin Res Cardiol 2021


Aschenbrenner S*, Kallenberger SM*, Hoffmann MD, Huck A, Eils R, Niopek D. Coupling Cas9 to artificial inhibitory domains enhances CRISPR-Cas9 target specificity. Science Advances 2020;6:eaay0187, (*shared first authors)


Starkuviene V*, Kallenberger SM*, Beil N, Lisauskas T, Schumacher BS-S, Bulkescher R, Wajda P, Gunkel M, Beneke J, Erfle H. High-Density Cell Arrays for Genome-Scale Phenotypic Screening. SLAS Discov. 2019;24: 274–283, (*shared first authors)


Maier LJ*, Kallenberger SM*, Jechow K, Waschow M, Eils R, Conrad C. Unraveling mitotic protein networks by 3D multiplexed epitope drug screening. Molecular Systems Biology 2018;14:e8238, (*shared first authors)


Kallenberger SM, Unger AL, Legewie S, Lymperopoulos K, Klingmüller U#, Eils R#, Herten DP#. Correlated receptor transport processes buffer single-cell heterogeneity. PLoS Comput Biol. 2017;13: e1005779, (#corresponding authors)


Kallenberger SM, Schmid C, Wiedmann F, Mereles D, Katus HA, Thomas D, Schmidt C. A Simple, Non-Invasive Score to Predict Paroxysmal Atrial Fibrillation. PloS One. 2016;11: e0163621.


Kallenberger SM*, Schmidt C*, Dechent P, Forster C, von Steinbüchel N, Wüstenberg T, Strasburger H. Separating fusion from rivalry. PloS One. 2014;9: e103037. doi:10.1371/journal.pone.0103037, (*shared first authors)


Kallenberger SM, Beaudouin J, Claus J, Fischer C, Sorger PK, Legewie S#, Eils R#. Intra- and interdimeric caspase-8 self-cleavage controls strength and timing of CD95-induced apoptosis. Science Signaling 2014;7:ra23 (#joint senior authors, "Editors' Choice" in Science Vol 343, 2014),


PAF Score Calculator

Latest News

SBHD 2024

Our colleagues at Vanderbilt University organise the 16th INTERNATIONAL CONFERENCE ON SYSTEMS BIOLOGY OF HUMAN DISEASE – SBHD 2024 this year from June 10-12. Don’t miss the opportunity to participate

Top 100 Köpfe der Wissenschaft 2023

Am 11.10.2023 wurde Prof. Roland Eils im Tagesspiegel als einer der 100 wichtigsten Köpfe der Hauptstadt-Wissenschaft gewürdigt. So schreibt der Tagesspiegel: "Um Big Data dreht sich alles in der

Young BIH scientists attend 72nd Lindau Nobel Laureate Meeting

The Lindau Nobel Laureate Meetings are annual conferences where some of the brightest minds in science converge to exchange knowledge, foster collaboration, and inspire the next generation of

Roland Eils wird als Highly Cited Researcher international gelistet.

Roland Eils gehört zu den weltweit am häufigsten zitierten Forschenden des Jahres 2022, wie aus der Liste der „Highly Cited Researchers“ hervorgeht, die das Unternehmen Clarivate heute veröffentlicht